ICG/SPY
Deviceindocyanine green fluorescence imaging
NCT Number: NCT02766244
Three patients were recruited for assessment of ICG fluorescence in burns.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Interventional
Not applicable
The early determination of healing potential in indeterminate thickness burns may be difficult to establish by visual inspection alone, even for experienced burn practitioners. This case series explores the use of indocyanine green (ICG) fluorescence using portable bedside assessment as a potential tool for early determination of burn depth. Three subjects with indeterminate thickness burns had daily perfusion assessment using ICG fluorescence assessment using the SPY machine (SPY®, Lifecell Corp., NJ, USA) in addition to standard burn care. The fluorescence was quantified as a percentage of the perfusion of intact skin, and areas of hypo and hyper-perfusion were indicated. The burn surgeon, blinded to the ICG results, made a clinical determination of the need for skin grafting or discharge. The perfusion in areas of differing depth of burn were compared over the entire study period to determine both the magnitude of difference, and the point in the time course of healing when these changes became evident.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
indocyanine green fluorescence imaging
Antibiotic ointment
Time frame: 5 days
Perfusion as measured by ICG Fluorescence
Texas Tech University Health Sciences Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07183943
Burns, Wounds and Injuries
Cairo, Egypt
View Trial DetailsNCT06116227
Burns, Wounds and Injuries
Cairo, Egypt
View Trial DetailsNCT07313735
Bandages, Behavior
Van, Turkey, Turkey (Türkiye)
View Trial DetailsNCT03692273
Burns, Cicatrix
Boston, Massachusetts, United States
View Trial Details